Fairchild Brothers & Foster

Fairchild Brothers & Foster was a drug manufacturer which was based in New York City in the 1930s.

Fairchild Brothers & Foster
IndustryDrug manufacturing
FateAcquired by Sterling Drug
FoundersThomas Fairchild, Samuel W. Fairchild, Malcomb G. Foster
Defunct1946 (1946)
Headquarters,
United States

Formation of company

Thomas Fairchild studied at Stratford Academy and graduated from Philadelphia College of Pharmacy. Afterward he joined Caswell Havard & Company of New York City. Later he organized Fairchild Brothers & Foster, together with his brother, Samuel W. Fairchild (d. 1927),[1][2] and Macomb G. Foster.[3]

Founders

Thomas Fairchild (18511939), of Quaker Ridge, New Rochelle, New York, who was born in Stratford, Connecticut, was one of the firm's founders, and its president.

Acquisition

The company was acquired by Sterling Drug, Inc., in February 1946. Fairchild Brothers & Foster specialized in making drugs to assist digestive disorders. Among the drugs it produced were Marinol, Phisoderm, and Enzymo.

Stearns & Company, a subsidiary of Sterling Drug, Inc., took over the distribution of all except three drugs made by the acquired concern. Winthrop Chemical Company, also a Sterling subsidiary, resumed the manufacture of Marinol, Phisoderm, and Enzymo.[4]

See also

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.